A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease
Clinical trial NCT04799158 · COMPLETED
Trial details
- NCT number
- NCT04799158
- Sponsor
- Phathom Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2021-12-16
- Enrollment
- 458
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.